- Q1 2024 Chimerix Inc Earnings Call TranscriptMay 01, 2024Earnings
- Q4 2023 Chimerix Inc Earnings Call TranscriptFeb 29, 2024€1.12 (-7.95%)Earnings
- Q3 2023 Chimerix Inc Earnings Call TranscriptNov 02, 2023€0.8992 (+2.51%)Earnings
- Q2 2023 Chimerix Inc Earnings Call TranscriptAug 03, 2023€1.04Earnings
- Chimerix Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Chimerix Inc Earnings Call TranscriptMay 04, 2023€1.02 (-0.44%)Earnings
- Q4 2022 Chimerix Inc Earnings Call TranscriptMar 02, 2023€1.55 (+6.01%)Earnings
- Chimerix Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 Chimerix Inc Earnings Call TranscriptNov 03, 2022€1.82 (-4.55%)Earnings
- Q2 2022 Chimerix Inc Earnings Call TranscriptAug 08, 2022€2.26 (-10.79%)Earnings
- Q1 2022 Chimerix Inc Earnings Call TranscriptMay 16, 2022€2.04 (-41.86%)Earnings
- Q4 2021 Chimerix Inc Earnings Call TranscriptMar 01, 2022€4.87 (-1.78%)Earnings
- Chimerix Inc to Discuss Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma Call TranscriptNov 22, 2021
- Chimerix Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 08, 2021
- Q3 2021 Chimerix Inc Earnings Call TranscriptNov 04, 2021€5.21 (+4.73%)Earnings
- Q2 2021 Chimerix Inc Earnings Call TranscriptAug 05, 2021€5.57 (+4.90%)Earnings
- Chimerix Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Q1 2021 Chimerix Inc Earnings Call TranscriptMay 06, 2021€6.6 (-11.06%)Earnings
- Q4 2020 Chimerix Inc Earnings Call TranscriptFeb 25, 2021€8.48 (+3.41%)Earnings
- Chimerix Inc to Acquire Oncoceutics Inc - Conference Call TranscriptJan 08, 2021
- Chimerix Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 12, 2020
- Q3 2020 Chimerix Inc Earnings Call TranscriptNov 05, 2020€2.5 (+0.81%)Earnings
- Q2 2020 Chimerix Inc Earnings Call TranscriptAug 10, 2020€2.68Earnings
- Chimerix Inc DSTAT Clinical Update Conference Call TranscriptApr 29, 2020
- Q4 2019 Chimerix Inc Earnings Call TranscriptFeb 25, 2020€1.71 (+11.76%)Earnings
- Chimerix Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 13, 2019
- Q3 2019 Chimerix Inc Earnings Call and Operational Updates TranscriptNov 05, 2019€1.39 (-2.11%)Earnings
- Chimerix Inc CX-01 Call TranscriptJul 31, 2019
- Q1 2019 Chimerix Inc Earnings Call TranscriptMay 09, 2019€2.5 (+6.38%)Earnings
- Q4 2018 Chimerix Inc Earnings Call TranscriptMar 05, 2019€1.8 (-8.16%)Earnings
Q3 2022 Chimerix Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Chimerix Third Quarter 2022 Earnings Conference Call. I would now like to introduce you to your host for today's call, Michelle LaSpaluto, Vice President of Strategic Planning and Investor Relations at Chimerix. Please proceed.
Thank you. Good morning, everyone, and welcome to -- this morning, we issued a press release on our third quarter operating update. You can access this press release in our Investors section of the website. With me on today's call are President and Chief Executive Officer, Mike Sherman; Chief Medical Officer, Allen Melemed; Chief Financial and Business Officer, Mike Andriole; Chief Science Officer, Randall Lanier; and our Chief Technology Officer of Imipridones, Josh Allen.
Before we begin, I'd like to remind you that the statements made on today's call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)